President Donald Trump said his decision on whether to change cannabis’s control status will come in the ‘next few weeks.’
by Tony Lange
President Donald Trump’s recent comments on cannabis rescheduling landed as the top trending storyline that Cannabis Business Times’ readers did not want to miss out on this month.
Nearly seven months after his inauguration, Trump broke his silence on the cannabis reform topic during a White House press conference on Aug. 11, when he told reporters “we’re looking at that,” and “we’ll make a determination … over the next few weeks.”
The Trump administration could
1 decide to resume the hearing
process under a new Drug Enforcement Administration (DEA) administrative
law judge,
2 move forward on the current proposed rule without the
hearing process by fast-tracking straight to a final rule,
3 start from
square one with a new scientific and medical review under the U.S.
Department of Health and Human Services,
4 or just scrap the reform
package altogether.
Taking the No. 2 spot in CBT’s Top 10 most-read articles this month was a piece on U.S. House Rep. Greg Steube, R-Fla., filing legislation to reclassify cannabis to a Schedule III substance—the Marijuana 1-to-3 Act—the day after Trump’s comments.
“It makes zero sense that federal law treats marijuana the same as heroin and LSD,” Steube said.
“It is even more ridiculous that cocaine is technically classified as less restrictive than marijuana.”
Other articles that readers did not want to miss out on in August included those on the
- Texas Senate passing another hemp THC ban bill in a second special session,
- AYR Wellness’ Massachusetts exit, and
- a well-known lawyer bringing to light that he alerted New York cannabis regulators more than a year ago that they were erroneously measuring buffer zones between dispensaries and schools.
Don’t miss out on our Top 10 stories from August 2025.
More in Cannabis Rescheduling
No comments:
Post a Comment